Dr. Yajing Jiang (姜娅婧) is a principal in the Antitrust & Competition Practice. Trained as a microeconomist, she is well equipped with state-of-the-art economic models for complex antitrust issues.

Yajing is dedicated to serving clients in highly dynamic environments, faced with challenging antitrust issues due to unique marketplace conditions that require a good handle of economic theories and data analytical skills. She leads quality teams to help solve clients’ real-world problems with an academic mindset.

During her tenure at CRA, Yajing has advised clients on merger and litigation cases involving multi-sided platforms, information technology, telecommunication, industrial chemicals, oil and gas, medical technology, travel and leisure products, agricultural products and services, and consumer retail goods in front of the antitrust authorities in the US, Europe, Canada, China, and other Asia-Pacific jurisdictions. She has extensive experience in evaluating the closeness of competition between horizontally overlapping products as well as testing vertical foreclosure and raising rivals’ costs theories of harm in the abovementioned industries.

Yajing serves as the Vice-Chair of the Economics Committee of the ABA Antitrust Law Section. She has previously served as the Young Economist Representative to the Committee and the International Cartel Task Force and is an editor of the newsletters published by the Economics Committee and Joint Conduct Committee at the ABA. She is a regular speaker at conferences in the antitrust community. She has published multiple articles in the various ABA newsletters, Competition Policy International, the Annual Review of Antitrust Law Developments, George Mason Law Review, and Australian Journal of Competition and Consumer Law. Yajing’s articles were nominated twice by the Concurrences’ Antitrust Writing Awards. She is a native mandarin speaker.

Noah Pinegar is a partner in the Antitrust & Competition Practice Group in the New York office of Kirkland & Ellis LLP. He represents clients in investigations of mergers and acquisitions and business conduct before the U.S. Department of Justice Antitrust Division and Federal Trade Commission, and in antitrust and competition litigation.

Noah leverages significant plaintiff/enforcement experience in antitrust matters, including his time with the Federal Trade Commission Bureau of Competition, where he litigated multiple merger challenges (FTC v. Staples/Office Depot and FTC v. Steris/Synergy Health), investigated M&A transactions in pharmaceuticals, pharmacies and medical devices, and earned multiple service awards. He has also litigated numerous monopolization cases in private practice, both for defendants and plaintiffs.

Noah has represented a wide range of clients, from leading public and private companies to internationally known authors, in situations ranging from bet-the-company investigations and litigation to tuck-in acquisitions and divestitures.